Hikma Partners Partnering helps us transform cutting-edge science into practical solutions Our global Business Development team helps put better health within reach, every day by in-licensing and acquiring innovative, NDA/ANDA, and generic high-quality medicines and making them accessible to the people who need them. Also, we transform cutting edge science into innovative solutions by providing access to Contract Manufacturing Organisations (CMO) businesses globally as we continue to transform people’s lives, for a healthier world, wherever we are. Please click here to submit your inquiry to Hikma's Business Development team Astellas Anti-Infectives and Immunosuppressants www.astellas.com ROVI Blood and Blood Forming and Cardiovascular www.rovi.es Celltrion Biological, Oncology and Rheumatology www.celltrion.com Takeda Cardiovascular, Gastrointestinal and Musco-Skeletal www.takeda.com Basilea Pharmaceutica Anti-infectives www.basilea.com Perrigo Consumer Health www.perrigo.com Orion Pharma Respiratory www.orion.fi Eisai Central Nervous System www.eisai.com Octapharma Blood and Blood Forming and Rare Diseases www.octapharma.com Vifor Pharma Blood and Blood-Forming and Anti-Anemic www.viforpharma.com Latest news Hikma and Winterlight Labs collaborate to develop biomarkers for Schizophrenia patients in MENA 23 November 2021 Hikma Ventures invests in biotechnology company BioSapien Inc., developer of a patented drug-delivery device intended to reduce the system-wide side effects of chemotherapy treatments 11 November 2021 Hikma continues strong 2021 performance and reiterates full year guidance 4 November 2021 About Partners Back to top Useful links About Products Investors News Careers Contact Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2021 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.